Endoprotech

Manufacturing · Kentucky, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1044 E Chestnut St Ste 8, Louisville, Ke...

Phone Number

(502) 468-1736

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Endoprotech

EndoProtech Inc. specializes in developing innovative liposome-based therapies aimed at treating microvascular dysfunction and myocardial infarction. Their research focuses on anti-inflammatory liposomes that enhance cell plasma membrane composition, thereby reducing microvascular dysfunction. The company's solutions are designed to minimize side effects, shorten recovery times, and preserve tissue viability. EndoProtech targets healthcare providers and patients seeking advanced therapeutic options for cardiovascular conditions.Explore more
Endoprotech's Social MediaPopular SearchesEndoProtech IncEndoprotechSIC Code 28,283NAICS Code 32,325Show more

Endoprotech Org Chart

CM
United States flag for contact location.

Founder, President & Chief Executive Officer

PhoneEmail
GP
United States flag for contact location.

Founder & Vice President & Treasurer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Endoprotech your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Endoprotech

Compare insights from companies similar to Endoprotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Endoprotech

<$5M
1-10
Private
<$5M
2004
CM
Claudio MaldonadoFounder, President & CEO
<$5M
11-50
Private
-
2018
N/A
<$5M
1-10
Private
<$5M
2016
Christa Pawlowski, Chief Operating Officer at Allinaire Therapeutics
Christa PawlowskiChief Operating Officer
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
2017
DA
Donna ArvansManager, Research Laboratory
<$5M
1-10
Private
-
2017
RT
Ruhab TahirAccount Manager
<$5M
1-10
Private
-
1999
SR
Stuart RingoldDirector, Operations (North America)
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Endoprotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Endoprotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Endoprotech.

Endoprotech financials insights

Gather financial insights about Endoprotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2021

Debt

$24K

See All Endoprotech's Financials Insights

Endoprotech Tech Stack

A closer look at the technologies used by Endoprotech

Top Manufacturing Companies

Frequently Asked Questions Regarding Endoprotech

What is Endoprotech's official website?
Endoprotech's official website is www.endoprotech.com
What is Endoprotech's Revenue?
Endoprotech's revenue is <$5 Million
What is Endoprotech's SIC code?
Endoprotech's SIC: 28,283
What is Endoprotech's NAICS code?
Endoprotech's NAICS: 32,325
How many employees does Endoprotech have?
Endoprotech has 1-10 employees
What industry does Endoprotech belong to?
Endoprotech is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Endoprotech competition?
Endoprotech top competitors include: Allinaire Therapeutics, Kiran Musunuru, Oxalo Therapeutics, Glycominds
What technology does Endoprotech use?
Some of the popular technologies that Endoprotech uses are: NS1, Google Cloud DNS, Squarespace Online Stores, Google Cloud Platform
How do I contact Endoprotech?
Endoprotech contact info: Phone number: (502) 468-1736 Website: www.endoprotech.com
What does Endoprotech do?

EndoProtech Inc. specializes in developing innovative liposome-based therapies aimed at treating microvascular dysfunction and myocardial infarction. Their research focuses on anti-inflammatory liposomes that enhance cell plasma membrane composition, thereby reducing microvascular dysfunction. The company's solutions are designed to minimize side e... ffects, shorten recovery times, and preserve tissue viability. EndoProtech targets healthcare providers and patients seeking advanced therapeutic options for cardiovascular conditions.Read More

What are Endoprotech social media links?
Endoprotech Linkedin page Endoprotech Facebook page
Is Endoprotech a public company?
Endoprotech is private company therefore does not currently have an official ticker symbol
See more information about Endoprotech

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.